Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association.

The aim of this updated statement is to provide comprehensive and timely evidence-based recommendations on the prevention of ischemic stroke among survivors of ischemic stroke or transient ischemic attack. Evidence-based recommendations are included for the control of risk factors, interventional approaches for atherosclerotic disease, antithrombotic treatments for cardioembolism, and the use of antiplatelet agents for noncardioembolic stroke. Further recommendations are provided for the prevention of recurrent stroke in a variety of other specific circumstances, including arterial dissections; patent foramen ovale; hyperhomocysteinemia; hypercoagulable states; sickle cell disease; cerebral venous sinus thrombosis; stroke among women, particularly with regard to pregnancy and the use of postmenopausal hormones; the use of anticoagulation after cerebral hemorrhage; and special approaches to the implementation of guidelines and their use in high-risk populations.

[1]  C. Friedberg DISEASES OF THE HEART , 1933, The Ulster Medical Journal.

[2]  P. Wood Diseases of the Heart and Circulation , 1902, The Hospital.

[3]  R. Desanctis,et al.  Massive calcification of the mitral annulus. A clinicopathological study of fourteen cases. , 1962, The New England journal of medicine.

[4]  P. Szekely Systemic Embolism and Anticoagulant Prophylaxis in Rheumatic Heart Disease , 1964, British medical journal.

[5]  B. Lytton,et al.  Antigenic Properties of Human Tumours: Delayed Cutaneous Hypersensitivity Reactions , 1964, British medical journal.

[6]  A. Carter Prognosis of cerebral embolism. , 1965, Lancet.

[7]  P. Olley,et al.  Incidence of systemic embolism before and after mitral valvotomy. , 1968, Thorax.

[8]  R. S. Kirk,et al.  Subvalvular calcification of mitral valve. , 1969, British heart journal.

[9]  E. Epstein,et al.  Systemic embolism in mitral valve disease. , 1970, British heart journal.

[10]  A. Carter,et al.  Hypotensive therapy in stroke survivors. , 1970, Lancet.

[11]  H. Fleming Anticoagulants in rheumatic heart-disease. , 1971, Lancet.

[12]  R. Gorlin,et al.  Pharmacologic control of thromboembolic complications of cardiac-valve replacement. , 1971, The New England journal of medicine.

[13]  Effect of antihypertensive treatment on stroke recurrence. Hypertension-Stroke Cooperative Study Group. , 1974, JAMA.

[14]  Mann Gv The influence of obesity on health (second of two parts). , 1974 .

[15]  G. Mann The influence of obesity on health (second of two parts). , 1974, The New England journal of medicine.

[16]  J. Merrett,et al.  Cerebral embolism and mitral stenosis: survival with and without anticoagulants , 1974, Journal of neurology, neurosurgery, and psychiatry.

[17]  J. Stamler Clofibrate and niacin in coronary heart disease. , 1975, JAMA.

[18]  H. Barnett,et al.  Cerebral ischemic events associated with prolapsing mitral valve. , 1976, Archives of neurology.

[19]  E. Crowell,et al.  Randomized prospective trial of continuous vs intermittent heparin therapy. , 1976, JAMA.

[20]  Hutchins Gm,et al.  Spontaneous calcific emboli from calcific mitral annulus fibrosus. , 1976 .

[21]  E. Myhre,et al.  Prevention of arterial thromboembolism with acetylsalicylic acid. A controlled clinical study in patients with aortic ball valves. , 1977, American heart journal.

[22]  J. Pitha,et al.  Continuing disease process of calcific aortic stenosis. Role of microthrombi and turbulent flow. , 1977, The American journal of cardiology.

[23]  G. Hirsowitz,et al.  Hemiplegia and the billowing mitral leaflet syndrome. , 1978, Journal of neurology, neurosurgery, and psychiatry.

[24]  Daniel L. McGee,et al.  Diabetes and cardiovascular disease. The Framingham study. , 1979, JAMA.

[25]  M. Han,et al.  Mitral valve prolapse: report of 3 cases , 1979 .

[26]  J. Talano,et al.  Transient ischemic attack associated with mitral systolic clicks. , 1979, Archives of internal medicine.

[27]  W. Kannel,et al.  Diabetes and cardiovascular disease. The Framingham study. , 1979, JAMA.

[28]  B. M. Beaver,et al.  Calcification of the mitral annulus: etiology, clinical associations, complications and therapy. , 1979, The American journal of medicine.

[29]  P. Kishore,et al.  Major intracerebral arterial involvement in sickle cell disease. , 1980, Surgical neurology.

[30]  C. Kerber,et al.  Catheter dilatation of proximal carotid stenosis during distal bifurcation endarterectomy. , 1980, AJNR. American journal of neuroradiology.

[31]  R. Adolph,et al.  Calcium emboli to the retinal artery in calcific aortic stenosis. , 1981, American heart journal.

[32]  R. Hart,et al.  Dissections of cervical and cerebral arteries. , 1983, Neurologic clinics.

[33]  V. Fuster,et al.  Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole. , 1983, The American journal of cardiology.

[34]  P. Shah,et al.  Effect of early systemic thrombolytic therapy on left ventricular mural thrombus formation in acute anterior myocardial infarction. , 1984, The American journal of cardiology.

[35]  J. Ross,et al.  Mitral annular calcification: clinical, pathophysiology, and echocardiographic review. , 1984, American heart journal.

[36]  M. Reivich,et al.  Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. , 1984, Blood.

[37]  J. Nordrehaug,et al.  Usefulness of high-dose anticoagulants in preventing left ventricular thrombus in acute myocardial infarction. , 1985, The American journal of cardiology.

[38]  C. Mok,et al.  Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial. , 1985, Circulation.

[39]  M. Davis,et al.  Effect of early anticoagulation on the frequency of left ventricular thrombi after anterior wall acute myocardial infarction. , 1986, The American journal of cardiology.

[40]  Denis Roy,et al.  Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation. , 1986, American heart journal.

[41]  R. Hull,et al.  Antithrombotic therapy for venous thromboembolic disease. , 1986, Chest.

[42]  P. Guéret,et al.  Effects of full-dose heparin anticoagulation on the development of left ventricular thrombosis in acute transmural myocardial infarction. , 1986, Journal of the American College of Cardiology.

[43]  M. Shipley,et al.  Stroke and alcohol consumption. , 1986, The New England journal of medicine.

[44]  P. Despland,et al.  Spontaneous carotid dissection with acute stroke. , 1987, Archives of neurology.

[45]  S. Arvan,et al.  Prophylactic anticoagulation for left ventricular thrombi after acute myocardial infarction: a prospective randomized trial. , 1987, American Heart Journal.

[46]  R B D'Agostino,et al.  Cigarette smoking as a risk factor for stroke. The Framingham Study. , 1988, JAMA.

[47]  D. Natarajan,et al.  Reduced incidence of left ventricular thrombi with intravenous streptokinase in acute anterior myocardial infarction: prospective evaluation by cross-sectional echocardiography. , 1988, International journal of cardiology.

[48]  W. Willett,et al.  A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. , 1988, The New England journal of medicine.

[49]  G. Reaven Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[50]  R. Adams,et al.  Cerebral infarction in sickle cell anemia , 1988, Neurology.

[51]  J. Alpert,et al.  Impact of thrombolytic therapy on left ventricular mural thrombi in acute myocardial infarction. , 1988, The American journal of cardiology.

[52]  D. Jacobs,et al.  Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. , 1989, The New England journal of medicine.

[53]  R. Asinger,et al.  Cardiogenic brain embolism. The second report of the Cerebral Embolism Task Force. , 1989, Archives of neurology.

[54]  V. Hachinski,et al.  THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKE , 1989, The Lancet.

[55]  V. Fuster,et al.  Left ventricular thrombi and cerebral embolism. , 1989, The New England journal of medicine.

[56]  Daniel B Hier,et al.  Weekly alcohol consumption, cigarette smoking, and the risk of ischemic stroke , 1989, Neurology.

[57]  H. Adams,et al.  A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. , 1989, The New England journal of medicine.

[58]  G. Beevers,et al.  Meta-analysis of relation between cigarette smoking and stroke. , 1989, BMJ.

[59]  C. Thomas,et al.  Vascular lesions in the central nervous system in sickle cell disease (neuropathology). , 1990, Journal of the Association for Academic Minority Physicians : the official publication of the Association for Academic Minority Physicians.

[60]  J. Broderick,et al.  Ultra-early evaluation of intracerebral hemorrhage. , 1990, Journal of neurosurgery.

[61]  M. Malinow,et al.  Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke. , 1990, Stroke.

[62]  A. Algra,et al.  A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. , 1991, The New England journal of medicine.

[63]  R. Clarke,et al.  Hyperhomocysteinemia: an independent risk factor for vascular disease. , 1991, The New England journal of medicine.

[64]  Daniel B Hier,et al.  Stroke recurrence within 2 years after ischemic infarction. , 1991, Stroke.

[65]  C. Warlow,et al.  MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis , 1991, The Lancet.

[66]  Ralph G. Dacey,et al.  Carotid Endarterectomy and Prevention of Cerebral Ischemia in Symptomatic Carotid Stenosis , 1991 .

[67]  D. Sackett,et al.  Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. , 1991, The New England journal of medicine.

[68]  J. Flier,et al.  Insulin resistance--mechanisms, syndromes, and implications. , 1991, The New England journal of medicine.

[69]  J. Manson,et al.  A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. , 1991, Archives of internal medicine.

[70]  C Warlow,et al.  The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[71]  E. Kenton Access to neurological care for minorities. , 1991, Archives of neurology.

[72]  A. Villringer,et al.  Heparin treatment in sinus venous thrombosis , 1991, The Lancet.

[73]  S. Levine,et al.  Risk of Recurrent Thromboembolic Events in Patients With Focal Cerebral Ischemia and Antiphospholipid Antibodies , 1992, Stroke.

[74]  R. Abbate,et al.  Lupus Anticoagulant and Anticardiolipin Antibodies in Young Adults With Cerebral Ischemia , 1992, Stroke.

[75]  J. Morris,et al.  Stroke in a cohort of patients with homozygous sickle cell disease. , 1992, The Journal of pediatrics.

[76]  S. Kittner,et al.  Antiphospholipid Antibodies and Stroke: An Epidemiological Perspective , 1992, Stroke.

[77]  W. Willett,et al.  A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. , 1992, JAMA.

[78]  W. Willett,et al.  Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. , 1993, The New England journal of medicine.

[79]  L. Wilkins Trial of Secondary Prevention With Atenolol After Transient Ischemic Attack or Nondisabling Ischemic Stroke , 1993, Stroke.

[80]  A. Laupacis,et al.  A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. , 1993, The New England journal of medicine.

[81]  J. Després,et al.  Abdominal obesity as important component of insulin-resistance syndrome. , 1993, Nutrition.

[82]  M. Staten,et al.  Insulin Resistance in Aging Is Related to Abdominal Obesity , 1993, Diabetes.

[83]  Després Jp Abdominal obesity as important component of insulin-resistance syndrome. , 1993, Nutrition.

[84]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.

[85]  R. Brey Anticardiolipin antibodies are an independent risk factor for first ischemic stroke , 1993, Neurology.

[86]  M. Pessin,et al.  Safety of anticoagulation after hemorrhagic infarction , 1993, Neurology.

[87]  Leandro Provinciali,et al.  Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993 .

[88]  B Rosner,et al.  Smoking cessation and decreased risk of stroke in women. , 1993, JAMA.

[89]  Donald A. Smith Fibrinogen as a cardiovascular risk factor: a meta-analysis , 1993, ACP Journal Club.

[90]  J. Neaton,et al.  Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.

[91]  F. Rosendaal,et al.  Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study , 1993, The Lancet.

[92]  G. Boysen,et al.  Lifestyle Factors and Risk of Cerebrovascular Disease in Women: The Copenhagen City Heart Study , 1993, Stroke.

[93]  B. Lindblad,et al.  Arterial and venous thromboembolism with fatal outcome and resistance to activated protein C , 1994, The Lancet.

[94]  B. Dahlbäck,et al.  Resistance to activated protein C as a basis for venous thrombosis. , 1994, The New England journal of medicine.

[95]  G. Leinsinger,et al.  Improvement of cerebrovascular reserve capacity by EC-IC arterial bypass surgery in patients with ICA occlusion and hemodynamic cerebral ischemia. , 1994, Journal of neurosurgery.

[96]  W. Halbmayer,et al.  The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects , 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[97]  Pieter H. Reitsma,et al.  Mutation in blood coagulation factor V associated with resistance to activated protein C , 1994, Nature.

[98]  E. Barbosa,et al.  Fabry's disease in a female carrier with bilateral thalamic infarcts: a case report and a family study. , 1994, Sao Paulo medical journal = Revista paulista de medicina.

[99]  Jeffrey R. Wilson,et al.  CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women , 1994, The Lancet.

[100]  S. Satterfield,et al.  Cigarette Smoking and Stroke in a Cohort of U.S. Male Physicians , 1994, Annals of Internal Medicine.

[101]  H. Tohgi,et al.  The anticardiolipin antibody in elderly stroke patients: its effects on stroke types, recurrence, and the coagulation‐fibrinolysis system , 1994, Acta neurologica Scandinavica.

[102]  Walker,et al.  Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .

[103]  C. Anderson,et al.  The Role of Lifestyle Factors in the Etiology of Stroke: A Population‐Based Case‐Control Study in Perth, Western Australia , 1994, Stroke.

[104]  K. Yano,et al.  Glucose Intolerance and 22‐Year Stroke Incidence: The Honolulu Heart Program , 1994, Stroke.

[105]  G. Rosner,et al.  Adiposity and stroke among older adults of low socioeconomic status: the Chicago Stroke Study. , 1994, American journal of public health.

[106]  J. Batlle,et al.  Prevalence, Follow-Up and Clinical Significance of the Anticardiolipin Antibodies in Normal Subjects , 1994, Thrombosis and Haemostasis.

[107]  K. Patrick,et al.  Physical Activity and Public Health: A Recommendation From the Centers for Disease Control and Prevention and the American College of Sports Medicine , 1995 .

[108]  B. Olofsson,et al.  Atenolol in Secondary Prevention after Stroke , 1995 .

[109]  P. Touboul,et al.  Time course of symptoms in extracranial carotid artery dissections. A series of 80 patients. , 1995, Stroke.

[110]  P. Prandoni,et al.  Ischemic stroke in young patients with activated protein C resistance. A report of three cases belonging to three different kindreds. , 1995, Stroke.

[111]  S. Ebrahim,et al.  Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men , 1995, The Lancet.

[112]  R. Sacco,et al.  Hypertension and diabetes mellitus as determinants of multiple lacunar infarcts. , 1995, Stroke.

[113]  S. Levine,et al.  Recurrent stroke and thrombo‐occlusive events in the antiphospholipid syndrome , 1995, Annals of neurology.

[114]  Pats-Collaborating-Group- Post-stroke antihypertensive treatment study. A preliminary result , 1995 .

[115]  W. O'Fallon,et al.  Mitral valve prolapse and the risk of stroke after initial cerebral ischemia , 1995, Neurology.

[116]  D. Reda,et al.  Effects of regular exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension. , 1995, The New England journal of medicine.

[117]  Scott T. Miller,et al.  Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. , 1995, The Journal of pediatrics.

[118]  A. Tverdal,et al.  Body mass index and cardiovascular mortality at different levels of blood pressure: a prospective study of Norwegian men and women. , 1995, Journal of epidemiology and community health.

[119]  P. Ridker,et al.  Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. , 1995, The New England journal of medicine.

[120]  A. Myers,et al.  Inhibition of platelet aggregation in whole blood by alcohol. , 1995, Thrombosis research.

[121]  Graham A. Colditz,et al.  Body weight and mortality among women , 1995 .

[122]  G. Omenn,et al.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. , 1995, JAMA.

[123]  M. Eberhardt,et al.  Report of the AAN Task Force on access to health care , 1996, Neurology.

[124]  W. J. Hamilton,et al.  Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial , 1996, The Lancet.

[125]  H. Diener,et al.  European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke 1 1 ESPS-2 Writing Committee , 1996, Journal of the Neurological Sciences.

[126]  P. Reitsma,et al.  A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.

[127]  J. Tuomilehto,et al.  Stroke around the Baltic Sea: incidence, case fatality and population risk factors in Denmark, Finland, Sweden and Lithuania , 1996 .

[128]  D. Abendschein,et al.  Sustained inhibition of whole-blood clot procoagulant activity by inhibition of thrombus-associated factor Xa. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[129]  D. Singer,et al.  An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. , 1996, The New England journal of medicine.

[130]  D. Clement A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996 .

[131]  D. Cossman,et al.  Spontaneous dissection of the internal carotid artery: a nineteen-year clinical experience. , 1996, Journal of vascular surgery.

[132]  G. Raskob,et al.  Aging and heparin-related bleeding. , 1996, Archives of internal medicine.

[133]  M. Dennis A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee , 1996 .

[134]  N. Pellegrini,et al.  Effects of moderate consumption of red wine on platelet aggregation and haemostatic variables in healthy volunteers. , 1996, European journal of clinical nutrition.

[135]  S. Wannamethee,et al.  Patterns of alcohol intake and risk of stroke in middle-aged British men. , 1996, Stroke.

[136]  D. Levy,et al.  Stenting: A New Approach to Carotid Dissection , 1997, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[137]  F. Verheugt,et al.  A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin , 1997, Annals of neurology.

[138]  D. Leys,et al.  Cervical artery dissections. , 1997, European neurology.

[139]  E. Vichinsky,et al.  Natural history of blood pressure in sickle cell disease: risks for stroke and death associated with relative hypertension in sickle cell anemia. , 1997, The American journal of medicine.

[140]  S. Levine,et al.  IgG anticardiolipin antibody titer > 40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study. , 1997, Stroke.

[141]  S. Kasner,et al.  Magnetic resonance angiography demonstrates vascular healing of carotid and vertebral artery dissections. , 1997, Stroke.

[142]  I. Martinelli,et al.  The transition G to A at position 20210 in the 3'-untranslated region of the prothrombin gene is not associated with cerebral ischemia. , 1997, Blood.

[143]  Cooper Es,et al.  Stroke in Elderly African-Americans. , 1997 .

[144]  B. Mokri SPONTANEOUS DISSECTIONS OF INTERNAL CAROTID ARTERIES , 1997 .

[145]  J. Manson,et al.  A prospective study of body mass index, weight change, and risk of stroke in women. , 1997, JAMA.

[146]  M. Evans,et al.  Body weight and mortality among women. , 1997, Canadian family physician Medecin de famille canadien.

[147]  W. Heiss,et al.  MRI- and MRA-guided therapy of carotid and vertebral artery dissections , 1997, Journal of the Neurological Sciences.

[148]  M. Hill,et al.  The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. , 1997, Circulation.

[149]  E. Uyama,et al.  High incidence of thrombosis in Fabry's disease. , 1997, Internal medicine.

[150]  D. A. Tam Protein C and Protein S Activity in Sickle Cell Disease and Stroke , 1997, Journal of child neurology.

[151]  R. Sacco,et al.  Cigarette smoking as a determinant of high-grade carotid artery stenosis in Hispanic, black, and white patients with stroke or transient ischemic attack. , 1998, Stroke.

[152]  R. Williamson,et al.  Thromboprophylaxis in the Cancer Patient , 1998, Pathophysiology of Haemostasis and Thrombosis.

[153]  P. Chiusolo,et al.  Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. , 1998, Blood.

[154]  L. Tatu,et al.  Stroke patterns of internal carotid artery dissection in 40 patients. , 1998, Stroke.

[155]  R. Sacco,et al.  Leisure-time physical activity and ischemic stroke risk: the Northern Manhattan Stroke Study. , 1998, Stroke.

[156]  Scott T. Miller,et al.  Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. , 1998, The New England journal of medicine.

[157]  P. Whelton,et al.  Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. , 1998, JAMA.

[158]  William J. Powers,et al.  Importance of Hemodynamic Factors in the Prognosis of Symptomatic Carotid Occlusion , 1998 .

[159]  R. Gibbons,et al.  ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease. Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). , 1998, The Journal of heart valve disease.

[160]  Scott T. Miller,et al.  Cerebrovascular accidents in sickle cell disease: rates and risk factors. , 1998, Blood.

[161]  F. Kirkham,et al.  Inherited prothrombotic states and ischaemic stroke in childhood , 1998, Journal of neurology, neurosurgery, and psychiatry.

[162]  M. Pessin,et al.  Proximal extracranial vertebral artery disease in the New England Medical Center Posterior Circulation Registry. , 1998, Archives of Neurology.

[163]  W. O'Fallon,et al.  Survival and recurrence after first cerebral infarction , 1998, Neurology.

[164]  Hann,et al.  Prothrombotic changes in children with sickle cell disease: relationships to cerebrovascular disease and transfusion , 1998, British journal of haematology.

[165]  Tait,et al.  Restarting anticoagulation in prosthetic heart valve patients after intracranial haemorrhage: a 2‐year follow‐up , 1998, British journal of haematology.

[166]  D. Sackett,et al.  Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. , 1998, The New England journal of medicine.

[167]  R. Gillum,et al.  Stroke in Blacks: A Guide to Management and Prevention , 1998 .

[168]  P. Gorelick Cerebrovascular disease in African Americans. , 1998, Stroke.

[169]  T. Raghunathan,et al.  Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant (G20210A) , 1998, Stroke.

[170]  H. Büller,et al.  Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. , 1999, Stroke.

[171]  V. Hachinski,et al.  The North American Symptomatic Carotid Endarterectomy Trial : surgical results in 1415 patients. , 1999, Stroke.

[172]  J. Connors,et al.  Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: evolution of technique and short-term results. , 1999, Journal of neurosurgery.

[173]  A. Pancioli,et al.  Incidence rates of first-ever ischemic stroke subtypes among blacks: a population-based study. , 1999, Stroke.

[174]  R A Levine,et al.  Prevalence and clinical outcome of mitral-valve prolapse. , 1999, The New England journal of medicine.

[175]  Eric S. Johnson,et al.  A metaregression analysis of the dose-response effect of aspirin on stroke. , 1999, Archives of internal medicine.

[176]  M. Margaglione,et al.  Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[177]  T. Truelsen,et al.  Passive smoking as well as active smoking increases the risk of acute stroke , 1999, Tobacco control.

[178]  J. McNeil,et al.  Ischemic stroke risk and passive exposure to spouses' cigarette smoking. Melbourne Stroke Risk Factor Study (MERFS) Group. , 1999, American journal of public health.

[179]  J. Gorter,et al.  Major bleeding during anticoagulation after cerebral ischemia , 1999, Neurology.

[180]  P. Whelton,et al.  Passive smoking and the risk of coronary heart disease--a meta-analysis of epidemiologic studies. , 1999, The New England journal of medicine.

[181]  I-Min Lee,et al.  Exercise and Risk of Stroke in Male Physicians , 1999 .

[182]  L Bozzao,et al.  Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. , 1999, Stroke.

[183]  J. Buring,et al.  Light-to-moderate alcohol consumption and the risk of stroke among U.S. male physicians. , 1999, The New England journal of medicine.

[184]  R. Feldman,et al.  The Three Leading Causes of Death in African Americans: Barriers to Reducing Excess Disparity and to Improving Health Behaviors , 1999, Journal of health care for the poor and underserved.

[185]  Wei Chen,et al.  Cardiovascular risk factors clustering features of insulin resistance syndrome (Syndrome X) in a biracial (Black-White) population of children, adolescents, and young adults: the Bogalusa Heart Study. , 1999, American journal of epidemiology.

[186]  P. Ridker,et al.  G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. , 1999, Circulation.

[187]  J M Zabramski,et al.  Guidelines for the management of spontaneous intracerebral hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. , 1999, Stroke.

[188]  R. Ware,et al.  Hydroxyurea as an Alternative to Blood Transfusions for the Prevention of Recurrent Stroke in Children With Sickle Cell Disease , 1999 .

[189]  Wei Chen,et al.  The association of cardiovascular risk factor clustering related to insulin resistance syndrome (Syndrome X) between young parents and their offspring: the Bogalusa Heart Study. , 1999, Atherosclerosis.

[190]  L. Brunereau,et al.  Long-term follow-up of aneurysms developed during extracranial internal carotid artery dissection , 1999, Neurology.

[191]  W A Wilson,et al.  International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. , 1999, Arthritis and rheumatism.

[192]  J. Manson,et al.  Exercise and risk of stroke in male physicians. , 1996, Stroke.

[193]  D. Albanes,et al.  Different risk factors for different stroke subtypes: association of blood pressure, cholesterol, and antioxidants. , 1999, Stroke.

[194]  R. Sacco,et al.  The protective effect of moderate alcohol consumption on ischemic stroke. , 1999, JAMA.

[195]  T. Rychlewski,et al.  The influence of short-term endurance training on the insulin blood level, binding, and degradation of 125I-insulin by erythrocyte receptors in patients after myocardial infarction. , 1999, Journal of cardiopulmonary rehabilitation.

[196]  S. Juvela,et al.  Recent heavy drinking of alcohol and embolic stroke. , 1999, Stroke.

[197]  P. Williamson,et al.  Antiphospholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease. , 1999, The Journal of laboratory and clinical medicine.

[198]  W R Bell,et al.  Thrombotic thrombocytopenic purpura associated with clopidogrel. , 2000, The New England journal of medicine.

[199]  S. Yusuf,et al.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .

[200]  W. Hacke,et al.  Managing the therapeutic dilemma: patients with spontaneous intracerebral hemorrhage and urgent need for anticoagulation , 2000, Journal of Neurology.

[201]  I. Bone,et al.  Interatrial septal abnormalities and stroke , 2000, Neurology.

[202]  Barry Katzen,et al.  Global experience in cervical carotid artery stent placement , 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[203]  S. Yusuf,et al.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .

[204]  S. Engelter,et al.  Antithrombotic drugs for carotid artery dissection. , 2004, The Cochrane database of systematic reviews.

[205]  P. Wahl,et al.  Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. , 2000, American journal of epidemiology.

[206]  B. Damasceno,et al.  Inherited Thrombophilia as a Risk Factor for the Development of Ischemic Stroke in Young Adults , 2000, Thrombosis and Haemostasis.

[207]  C. Spencer,et al.  Bupropion , 2000, Drugs.

[208]  G A Colditz,et al.  Physical activity and risk of stroke in women. , 2000, JAMA.

[209]  J. Halperin,et al.  Stroke in patients with heart failure and reduced left ventricular ejection fraction , 2000, Neurology.

[210]  P. Koudstaal Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacks. , 2000, The Cochrane database of systematic reviews.

[211]  S. Sidney,et al.  Short-term prognosis after emergency department diagnosis of TIA. , 2000, JAMA.

[212]  T. Pearson,et al.  The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. , 2000, Archives of internal medicine.

[213]  À. Rovira,et al.  Cerebral microembolism in acute spontaneous internal carotid artery dissection , 2000, Neurology.

[214]  T. van der Poll,et al.  Novel approaches to the management of disseminated intravascular coagulation , 2000, Critical care medicine.

[215]  R J Shephard,et al.  The economic burden of physical inactivity in Canada. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[216]  E. Fracassi,et al.  Waist circumference and abdominal sagittal diameter as surrogates of body fat distribution in the elderly: their relation with cardiovascular risk factors , 2000, International Journal of Obesity.

[217]  J R Hughes,et al.  Antidepressants for smoking cessation. , 2007, The Cochrane database of systematic reviews.

[218]  A M Malek,et al.  Carotid artery stent placement for atherosclerotic disease: rationale, technique, and current status. , 2000, Radiology.

[219]  E. Wijdicks,et al.  Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk. , 2000, Archives of neurology.

[220]  W. Rogers,et al.  Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. , 2000, Journal of the American College of Cardiology.

[221]  U Kaul,et al.  Elective stenting of extracranial carotid arteries. , 1997, The Journal of the Association of Physicians of India.

[222]  S. Engelter,et al.  Long-Term Follow-Up after Extracranial Internal Carotid Artery Dissection , 2000, European Neurology.

[223]  R. Perera,et al.  Nicotine replacement therapy for smoking cessation. , 2012, The Cochrane database of systematic reviews.

[224]  Y. Meng,et al.  CYP11B2 Expression in Rat Liver and the Effect of Spironolactone on Hepatic Fibrogenesis , 2001, Hormone Research in Paediatrics.

[225]  B. McNeil,et al.  Measuring and improving quality of care : A report from the american heart Association/American college of cardiology first scientific forum on assessment of healthcare quality in cardiovascular disease and stroke , 2000, Stroke.

[226]  E KoplanKate,et al.  Smoking Cessation , 2000 .

[227]  S. Yusuf,et al.  Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. , 2001, The New England journal of medicine.

[228]  H. Kwiecinski,et al.  Factor V Leiden, Prothrombin Gene G20210A Variant, and Methylenetetrahydrofolate Reductase C677T Genotype in Young Adults With Ischemic Stroke , 2001, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[229]  G. Hankey,et al.  Inherited Thrombophilia in Ischemic Stroke and Its Pathogenic Subtypes , 2001, Stroke.

[230]  M. Gladwin,et al.  Regional Cerebral Hyperperfusion and Nitric Oxide Pathway Dysregulation in Fabry Disease: Reversal by Enzyme Replacement Therapy , 2001, Circulation.

[231]  Alastair Baker,et al.  Crossing the Quality Chasm: A New Health System for the 21st Century , 2001, BMJ : British Medical Journal.

[232]  Physical activity trends--United States, 1990-1998. , 2001, MMWR. Morbidity and mortality weekly report.

[233]  C. Eng,et al.  Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease. , 2001, The New England journal of medicine.

[234]  D. Redelmeier,et al.  Mortality among patients admitted to hospitals on weekends as compared with weekdays. , 2001, The New England journal of medicine.

[235]  K. Sullivan,et al.  Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. , 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[236]  C. Viscoli,et al.  A clinical trial of estrogen-replacement therapy after ischemic stroke. , 2001, The New England journal of medicine.

[237]  D. Wood,et al.  Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries , 2001, The Lancet.

[238]  A. Wade,et al.  Nocturnal hypoxaemia and central-nervous-system events in sickle-cell disease , 2001, The Lancet.

[239]  C. Wolfe,et al.  Cerebrovascular Risk Factors and Stroke Subtypes: Differences Between Ethnic Groups , 2001, Stroke.

[240]  J. Marler,et al.  Advances in the genetics of cerebrovascular disease and stroke , 2001, Neurology.

[241]  D. Altmann,et al.  Exploring the relationship between alcohol consumption and non-fatal or fatal stroke: a systematic review. , 2001, Addiction.

[242]  V F Froelicher,et al.  Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. , 2001, Circulation.

[243]  P. Lichtenstein,et al.  Increased Risks of Circulatory Diseases in Late Pregnancy and Puerperium , 2001, Epidemiology.

[244]  J. Coste,et al.  Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. , 2001, The New England journal of medicine.

[245]  Steven Shea,et al.  Race-Ethnic Disparities in the Impact of Stroke Risk Factors: The Northern Manhattan Stroke Study , 2001, Stroke.

[246]  R. Zimmerman,et al.  Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity. , 2001, Archives of neurology.

[247]  J M Bland,et al.  Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial , 2001, The Lancet.

[248]  M. Woodward,et al.  Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack , 2001 .

[249]  K. Furie,et al.  A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. , 2001, The New England journal of medicine.

[250]  S. Borzak,et al.  How safely and for how long can warfarin therapy be withheld in prosthetic heart valve patients hospitalized with a major hemorrhage? , 2001, Chest.

[251]  G. Friedman,et al.  Alcohol drinking and risk of hospitalization for ischemic stroke. , 2001, The American journal of cardiology.

[252]  L. Brass,et al.  Reduction in Stroke With Gemfibrozil in Men With Coronary Heart Disease and Low HDL Cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT) , 2001, Circulation.

[253]  Richard F. Macko,et al.  Alcohol Intake, Type of Beverage, and the Risk of Cerebral Infarction in Young Women , 2001, Stroke.

[254]  W. Hacke,et al.  Hemorrhagic Transformation of Ischemic Brain Tissue: Asymptomatic or Symptomatic? , 2001, Stroke.

[255]  Robert J. Desnick,et al.  Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy. , 2001, The New England journal of medicine.

[256]  Eric E. Smith,et al.  Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke , 2002, Neurology.

[257]  R. Hobson Update on the Carotid Revascularization Endarterectomy versus Stent Trial (CREST) protocol. , 2002, Journal of the American College of Surgeons.

[258]  G. Mensah,et al.  Physician Advice, Patient Actions, and Health-Related Quality of Life in Secondary Prevention of Stroke Through Diet and Exercise , 2002, Stroke.

[259]  James F Sallis,et al.  AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. , 2002, Circulation.

[260]  E. Rothenberg,et al.  Waist Circumference, Body Mass Index, and Risk for Stroke in Older People , 2002, Journal of the American Geriatrics Society.

[261]  M L Simoons,et al.  A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). , 2002, European heart journal.

[262]  A. Connor,et al.  The way I see it: House officers need formal career development , 2002 .

[263]  Nancy R Cook,et al.  Body mass index and the risk of stroke in men. , 2002, Archives of internal medicine.

[264]  J. Fleg,et al.  Secondary Prevention of Coronary Heart Disease in the Elderly (With Emphasis on Patients ≥75 Years of Age): An American Heart Association Scientific Statement From the Council on Clinical Cardiology Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention , 2002, Circulation.

[265]  B. Nordestgaard,et al.  Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses. , 2002, Blood.

[266]  W Klein,et al.  Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE). , 2002, European heart journal.

[267]  Deborah Grady,et al.  Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). , 2002, JAMA.

[268]  S. Ryu,et al.  Carotid Artery Stenosis in Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation , 2002, Cerebrovascular Diseases.

[269]  D. Graham,et al.  Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. , 2002, Archives of internal medicine.

[270]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[271]  G. Koren,et al.  Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. , 2002, American journal of obstetrics and gynecology.

[272]  K. Christensen,et al.  Cessation of Smoking After First-Ever Stroke: A Follow-Up Study , 2002, Stroke.

[273]  W. Hacke,et al.  The Carotid Surgery for Ischemic Stroke trial: a prospective observational study on carotid endarterectomy in the early period after ischemic stroke. , 2002, Journal of vascular surgery.

[274]  C. Wongvipaporn,et al.  A prognostic model for predicting the disappearance of left atrial thrombi among candidates for percutaneous transvenous mitral commissurotomy. , 2002, Journal of the American College of Cardiology.

[275]  M. MacKay-Lyons,et al.  Cardiovascular stress during a contemporary stroke rehabilitation program: is the intensity adequate to induce a training effect? , 2002, Archives of physical medicine and rehabilitation.

[276]  R. Sacco,et al.  Effect of Medical Treatment in Stroke Patients With Patent Foramen Ovale: Patent Foramen Ovale in Cryptogenic Stroke Study , 2002, Circulation.

[277]  V. Fairbanks,et al.  Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA) , 2002, American journal of hematology.

[278]  J. Borg,et al.  Antiphospholipid Antibodies in the Acute Phase of Cerebral Ischaemia in Young Adults: A Descriptive Study of 139 Patients , 2002, Cerebrovascular Diseases.

[279]  G. Di Minno,et al.  Hyperhomocysteinemia and Other Inherited Prothrombotic Conditions in Young Adults With a History of Ischemic Stroke , 2002, Stroke.

[280]  W. Dietz,et al.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.

[281]  R. D'Agostino,et al.  Alcohol Consumption and Risk of Ischemic Stroke: The Framingham Study , 2002, Stroke.

[282]  Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. , 2002 .

[283]  R. Steen,et al.  The effect of hydroxyurea on vasculopathy in a child with sickle cell disease. , 2002, AJNR. American journal of neuroradiology.

[284]  E. Poehlman,et al.  Weight Loss Reduces C-Reactive Protein Levels in Obese Postmenopausal Women , 2002, Circulation.

[285]  Catherine Sudlow,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[286]  Qingbo Xu,et al.  Active and Passive Smoking, Chronic Infections, and the Risk of Carotid Atherosclerosis: Prospective Results From the Bruneck Study , 2002, Stroke.

[287]  Diane K Wagener,et al.  Trends in racial and ethnic-specific rates for the health status indicators: United States, 1990-98. , 2002, Healthy People 2000 statistical notes.

[288]  Silvana Quaglini,et al.  Guideline Compliance Improves Stroke Outcome: A Preliminary Study in 4 Districts in the Italian Region of Lombardia , 2002, Stroke.

[289]  G. deVeber,et al.  Anticoagulation for cerebral sinus thrombosis. , 2003, Stroke.

[290]  P. Rothwell,et al.  Prognosis of vertebrobasilar transient ischaemic attack and minor stroke. , 2003, Brain : a journal of neurology.

[291]  D. Hanley,et al.  Prevalence and knowledge of transient ischemic attack among US adults , 2003, Neurology.

[292]  K. Miura,et al.  High-Density Lipoprotein Cholesterol and Risk of Stroke in Japanese Men and Women: The Oyabe Study , 2003, Stroke.

[293]  C. Kooperberg,et al.  Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. , 2003, JAMA.

[294]  L. Lisabeth,et al.  Access to Care, Acculturation, and Risk Factors for Stroke in Mexican Americans: The Brain Attack Surveillance in Corpus Christi (BASIC) Project , 2003, Stroke.

[295]  P. Rothwell,et al.  Relationship Between Blood Pressure and Stroke Risk in Patients With Symptomatic Carotid Occlusive Disease , 2003, Stroke.

[296]  A. Folsom,et al.  Physical Activity and Stroke Risk: A Meta-Analysis , 2003, Stroke.

[297]  Risk Factors for Death or Stroke After Carotid Endarterectomy: Observations From the Ontario Carotid Endarterectomy Registry , 2003 .

[298]  D. Singer,et al.  Can Patients Be Anticoagulated After Intracerebral Hemorrhage?: A Decision Analysis , 2003, Stroke.

[299]  S. Jencks,et al.  Change in the quality of care delivered to Medicare beneficiaries, 1998-1999 to 2000-2001. , 2003, JAMA.

[300]  C. Wolfe,et al.  Cause of Stroke Recurrence Is Multifactorial: Patterns, Risk Factors, and Outcomes of Stroke Recurrence in the South London Stroke Register , 2003, Stroke.

[301]  J. Gauvrit,et al.  Risk of stroke and recurrent dissection after a cervical artery dissection , 2003, Neurology.

[302]  B. Hoogwerf,et al.  The Heart Protection Study: high-risk patients benefit from statins, regardless of LDL-C level. , 2003, Cleveland Clinic journal of medicine.

[303]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[304]  P. Ridker,et al.  Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. , 2003, The New England journal of medicine.

[305]  Ka Sing Wong,et al.  Cerebral Microbleeds as a Risk Factor for Subsequent Intracerebral Hemorrhages Among Patients With Acute Ischemic Stroke , 2003, Stroke.

[306]  J. Saver,et al.  Epidemiological Impact in the United States of a Tissue-Based Definition of Transient Ischemic Attack , 2003, Stroke.

[307]  R. Levy,et al.  Treatment of pregnant patients with antiphospholipid syndrome , 2003, Lupus.

[308]  A. Mokdad,et al.  Trends in waist circumference among U.S. adults. , 2003, Obesity research.

[309]  A. Arauz,et al.  Prospective Study of Single and Multiple Lacunar Infarcts Using Magnetic Resonance Imaging: Risk Factors, Recurrence, and Outcome in 175 Consecutive Cases , 2003, Stroke.

[310]  Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial. , 2003 .

[311]  R. Grubb,et al.  Guidelines for the Early Management of Patients With Ischemic Stroke: A Scientific Statement From the Stroke Council of the American Stroke Association , 2003, Stroke.

[312]  M. Eliasziw,et al.  Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis , 2003, The Lancet.

[313]  I Campbell,et al.  Nicotine replacement therapy in smoking cessation. , 2003, Thorax.

[314]  J. Leonardi-Bee,et al.  Blood Pressure Reduction and Secondary Prevention of Stroke and Other Vascular Events: A Systematic Review , 2003, Stroke.

[315]  H. Honest,et al.  Aspirin for Prevention of Preeclampsia in Women With Historical Risk Factors: A Systematic Review , 2003, Obstetrics and gynecology.

[316]  M. Endres,et al.  Mechanisms of stroke protection by physical activity , 2003, Annals of neurology.

[317]  Ralph L. Sacco,et al.  Abdominal Obesity and Risk of Ischemic Stroke: The Northern Manhattan Stroke Study , 2003, Stroke.

[318]  J. Douketis,et al.  A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. , 2003, The New England journal of medicine.

[319]  R. Becker,et al.  Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. , 2003, American heart journal.

[320]  L. Vignolo,et al.  Inherited Thrombophilic Disorders in Young Adults With Ischemic Stroke and Patent Foramen Ovale , 2003, Stroke.

[321]  Paul Khairy,et al.  Transcatheter Closure versus Medical Therapy of Patent Foramen Ovale and Presumed Paradoxical Thromboemboli , 2003, Annals of Internal Medicine.

[322]  G. Albers,et al.  Spinal manipulative therapy is an independent risk factor for vertebral artery dissection , 2003, Neurology.

[323]  D. Allison,et al.  Years of life lost due to obesity. , 2003, JAMA.

[324]  F. Turnbull Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials , 2003, The Lancet.

[325]  H. Markus,et al.  Diagnosis and management of vertebral artery stenosis. , 2003, QJM : monthly journal of the Association of Physicians.

[326]  N. Feldstein,et al.  Sickle cell anemia with moyamoya disease: outcomes after EDAS procedure. , 2003, Pediatric neurology.

[327]  Fernando Costa,et al.  Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Ph , 2003, Circulation.

[328]  M. Borrego,et al.  Ought dialysis patients with atrial fibrillation be treated with oral anticoagulants? , 2003, International journal of cardiology.

[329]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[330]  M. Hennerici,et al.  Design and Baseline Characteristics of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study , 2003, Cerebrovascular Diseases.

[331]  S. Studenski,et al.  Randomized clinical trial of therapeutic exercise in subacute stroke. , 2003, Stroke.

[332]  A. Tuttolomondo,et al.  Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project. , 2003, Stroke.

[333]  L. Chambless,et al.  Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. , 2004, JAMA.

[334]  R. Hebbel,et al.  Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygenation and inhibited by lovastatin. , 2004, Blood.

[335]  S. Lewis Statin therapy in the elderly: observational and randomized controlled trials support event reduction. , 2004, The American journal of geriatric cardiology.

[336]  K. Sotaniemi,et al.  Cerebral CT and MRI findings in cervicocephalic artery dissection , 2004, Acta radiologica.

[337]  H. Diener,et al.  Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial , 2004, The Lancet.

[338]  Anthony Rodgers,et al.  Blood Pressure and Stroke: An Overview of Published Reviews , 2004, Stroke.

[339]  C. O'connor,et al.  The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics. , 2004, Journal of cardiac failure.

[340]  P. Touboul,et al.  Stroke prevention, blood cholesterol, and statins , 2004, The Lancet Neurology.

[341]  Neil J Stone,et al.  Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines , 2004, Circulation.

[342]  A. Greinacher,et al.  Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.

[343]  M. Sandler,et al.  Alcohol, wine and mental health: focus on dementia and stroke , 2004, Journal of psychopharmacology.

[344]  A. Culebras,et al.  Triflusal vs aspirin for prevention of cerebral infarction , 2004, Neurology.

[345]  T. Jacob,et al.  Carotid Endarterectomy in Octogenarians and Nonagenarians: Is it Worth the Effort ? , 2004, Acta chirurgica Belgica.

[346]  R. Collins,et al.  Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions , 2004, The Lancet.

[347]  A. Algra,et al.  Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. , 2004, Atherosclerosis.

[348]  R. Sacco,et al.  Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. , 2004, JAMA.

[349]  M. Sturzenegger Spontaneous internal carotid artery dissection: Early diagnosis and management in 44 patients , 1995, Journal of Neurology.

[350]  M. Schwerzmann,et al.  Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. , 2004, Journal of the American College of Cardiology.

[351]  D. Levy,et al.  Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study. , 2004, The American journal of cardiology.

[352]  Katherine Esposito,et al.  Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. , 2004 .

[353]  Fernando Costa,et al.  Physical activity and exercise recommendations for stroke survivors: an American Heart Association scientific statement from the Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention; the Council on Cardiovascular Nursing; the Council on Nutrition, Physical , 2004, Stroke.

[354]  M. Oğuz,et al.  Vein of Galen and sinus thrombosis with bilateral thalamic infarcts in sickle cell anaemia: CT follow-up and angiographic demonstration , 2004, Neuroradiology.

[355]  D. Corella,et al.  Factor V Leiden and prothrombin G20210A mutations in young adults with cryptogenic ischemic stroke , 2004, Thrombosis and Haemostasis.

[356]  S. Greenberg,et al.  Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage , 2004, Neurology.

[357]  Giancarlo Agnelli,et al.  Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.

[358]  A. Hingorani,et al.  Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. , 2004, Archives of neurology.

[359]  K. Jamerson,et al.  The Disproportionate Impact of Hypertensive Cardiovascular Disease in African Americans: Getting to the Heart of the Issue , 2004, Journal of clinical hypertension.

[360]  J. Saver,et al.  In-Hospital Initiation of Secondary Stroke Prevention Therapies Yields High Rates of Adherence at Follow-up , 2004, Stroke.

[361]  D. Torres-Russotto,et al.  Carotid endarterectomy in SAPPHIRE-eligible high-risk patients: implications for selecting patients for carotid angioplasty and stenting. , 2004, Journal of vascular surgery.

[362]  M. Monreal,et al.  Fixed‐dose low‐molecular‐weight heparin for secondary prevention of venous thromboembolism in patients with disseminated cancer: a prospective cohort study , 2004, Journal of thrombosis and haemostasis : JTH.

[363]  Satoshi Sasaki,et al.  Alcohol Consumption and Risk of Stroke Among Middle-Aged Men: The JPHC Study Cohort I , 2004, Stroke.

[364]  U. P. S. T. Force,et al.  Screening and Behavioral Counseling Interventions in Primary Care To Reduce Alcohol Misuse: Recommendation Statement , 2004, Annals of Internal Medicine.

[365]  P. Touboul,et al.  Statins in Stroke Prevention and Carotid Atherosclerosis: Systematic Review and Up-to-Date Meta-Analysis , 2004, Stroke.

[366]  M. Eliasziw,et al.  Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery , 2004, The Lancet.

[367]  J. Bogousslavsky,et al.  Stroke patterns, etiology, and prognosis in patients with diabetes mellitus , 2004, Neurology.

[368]  S. Quaglini,et al.  Economic benefit from clinical practice guideline compliance in stroke patient management. , 2004, Health policy.

[369]  S. Mehraein,et al.  Cerebral venous and sinus thrombosis , 2004, Journal of Neurology.

[370]  R. Desnick,et al.  Long-term safety and efficacy of enzyme replacement therapy for Fabry disease. , 2004, American journal of human genetics.

[371]  Stephen L Hillis,et al.  Effects of weekend admission and hospital teaching status on in-hospital mortality. , 2004, The American journal of medicine.

[372]  T. Brandt,et al.  Association of cervical artery dissection with connective tissue abnormalities in skin and arteries. , 2005, Frontiers of neurology and neuroscience.

[373]  H. Diener,et al.  Morbidity and Mortality After Stroke, Eprosartan Compared With Nitrendipine for Secondary Prevention: Principal Results of a Prospective Randomized Controlled Study (MOSES) , 2005, Stroke.

[374]  Erland Erdmann,et al.  Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial , 2005, The Lancet.

[375]  P. Lee,et al.  Association of the metabolic syndrome with intracranial atherosclerotic stroke , 2005, Neurology.

[376]  A. Tapaninaho Deep vein thrombosis after aneurysm surgery , 2005, Acta Neurochirurgica.

[377]  J. Yadav,et al.  Drug-Eluting Stents for the Treatment of Intracranial Atherosclerosis: Initial Experience and Midterm Angiographic Follow-up , 2005, Stroke.

[378]  H. Woo,et al.  Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: midterm analysis of clinical and radiologic predictors of neurological morbidity and mortality. , 2005, AJNR. American journal of neuroradiology.

[379]  E. Myers,et al.  Incidence and Risk Factors for Stroke in Pregnancy and the Puerperium , 2005 .

[380]  A. Tuttolomondo,et al.  Stroke patterns, etiology, and prognosis in patients with diabetes mellitus. , 2005, Neurology.

[381]  P. Bauer,et al.  Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study , 2005, The Lancet.

[382]  W. Budts,et al.  Percutaneous closure of a patent foramen ovale: single-centre experience using different types of devices and mid-term outcome , 2005, Acta cardiologica.

[383]  S. Kasner,et al.  Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. , 2005, The New England journal of medicine.

[384]  Dong Joon Kim,et al.  Stent-assisted angioplasty of symptomatic intracranial vertebrobasilar artery stenosis: feasibility and follow-up results. , 2005, AJNR. American journal of neuroradiology.

[385]  H. Minuk,et al.  Metabolic syndrome. , 2005, Journal of insurance medicine.

[386]  L. Chiche,et al.  Spontaneous Dissection of the Extracranial Vertebral Artery: Indications and Long-Term Outcome of Surgical Treatment , 2005, Annals of vascular surgery.

[387]  D. Tanné,et al.  Relation Between the Metabolic Syndrome and Ischemic Stroke or Transient Ischemic Attack: A Prospective Cohort Study in Patients With Atherosclerotic Cardiovascular Disease , 2005, Stroke.

[388]  P. Gorelick,et al.  Impact of obesity and the metabolic syndrome on risk factors in African American stroke survivors: a report from the AAASPS. , 2005, Archives of neurology.

[389]  J. Piette,et al.  Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome , 2005, Annals of the rheumatic diseases.

[390]  M. Schwerzmann,et al.  Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients. , 2005, Journal of the American College of Cardiology.

[391]  J. Stam Thrombosis of the cerebral veins and sinuses. , 2005, The New England journal of medicine.

[392]  D. Mikhailidis,et al.  Components of the Metabolic Syndrome and Risk for First-Ever Acute Ischemic Nonembolic Stroke in Elderly Subjects , 2005, Stroke.

[393]  T. Mayer,et al.  Stent-angioplasty of intracranial vertebral and basilar artery stenoses in symptomatic patients. , 2005, European journal of radiology.

[394]  Fuad M. Kiblawi,et al.  Transcatheter closure of patent foramen ovale in older adults , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[395]  R. Kothari,et al.  Quality of hospital care in African American and white patients with ischemic stroke and TIA , 2006, Neurology.

[396]  Gelin Xu,et al.  Recurrence after Ischemic Stroke in Chinese Patients: Impact of Uncontrolled Modifiable Risk Factors , 2006, Cerebrovascular Diseases.

[397]  P. H. Williams,et al.  Does a higher 'quality points' score mean better care in stroke? An audit of general practice medical records. , 2006, Informatics in primary care.

[398]  Bijoy K Khandheria,et al.  Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. , 2006, Journal of the American College of Cardiology.

[399]  P. Gorelick,et al.  Predictors of recurrent stroke in African Americans , 2006, Neurology.

[400]  S. Tonstad,et al.  Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. , 2006, JAMA.

[401]  V. Chair,et al.  Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the , 2006, Circulation.

[402]  J. Buring,et al.  Effects of Conjugated Equine Estrogen on Stroke in the Women’s Health Initiative , 2006, Circulation.

[403]  S. Grundy,et al.  Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. , 2006, Journal of the American College of Cardiology.

[404]  D. Lawlor,et al.  Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study , 2006, BMJ : British Medical Journal.

[405]  W. Wilcox,et al.  Improvement in serial cardiopulmonary exercise testing following enzyme replacement therapy in Fabry disease , 2006, Journal of Inherited Metabolic Disease.

[406]  S. Connolly,et al.  Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials. , 2006, American heart journal.

[407]  Daniel R Wong,et al.  Defining the high-risk patient for carotid endarterectomy: an analysis of the prospective National Surgical Quality Improvement Program database. , 2006, Journal of vascular surgery.

[408]  H. Ju,et al.  Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy. , 2006, The American journal of cardiology.

[409]  M. Marks,et al.  Angioplasty for Symptomatic Intracranial Stenosis: Clinical Outcome , 2006, Stroke.

[410]  D. Leys,et al.  Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. , 2006, The New England journal of medicine.

[411]  L. Niskanen,et al.  Metabolic Syndrome and the Risk of Stroke in Middle-Aged Men , 2006, Stroke.

[412]  Ralph B D'Agostino,et al.  Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study. , 2006, Archives of internal medicine.

[413]  W. Hacke,et al.  30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial , 2006, The Lancet.

[414]  Patrice Cacoub,et al.  Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. , 2006, The New England journal of medicine.

[415]  B. Hugl,et al.  Effect of Age and Gender on Restenosis after Carotid Endarterectomy , 2006, Annals of vascular surgery.

[416]  B. Levin,et al.  Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): rationale, objectives, and design. , 2006, Journal of cardiac failure.

[417]  C. Bai,et al.  Influence of Metabolic Syndrome and General Obesity on the Risk of Ischemic Stroke , 2006, Stroke.

[418]  S. Yusuf,et al.  Homocysteine lowering with folic acid and B vitamins in vascular disease. , 2006, The New England journal of medicine.

[419]  Metabolic Syndrome as an Independent Risk Factor of Silent Brain Infarction in Healthy People , 2006 .

[420]  M. Pfeffer,et al.  Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial , 2006, The Lancet.

[421]  A. Algra,et al.  Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial , 2006, The Lancet.

[422]  E Vicaut,et al.  Prospective study of symptomatic atherothrombotic intracranial stenoses , 2006, Neurology.

[423]  D. Thatai,et al.  Pharmacological Prevention of Thromboembolism in Patients with Left Ventricular Dysfunction , 2006, American journal of cardiovascular drugs : drugs, devices, and other interventions.

[424]  S. Kasner,et al.  Predictors of Ischemic Stroke in the Territory of a Symptomatic Intracranial Arterial Stenosis , 2006, Circulation.

[425]  S. Brodie,et al.  Fabry disease: Guidelines for the evaluation and management of multi-organ system involvement , 2006, Genetics in Medicine.

[426]  Seung-Hoon Lee,et al.  Metabolic syndrome as an independent risk factor of silent brain infarction in healthy people. , 2006, Stroke.

[427]  S. Grundy,et al.  Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study , 2006, The Lancet.

[428]  W. O'Fallon,et al.  Population-based study of the relationship between patent foramen ovale and cerebrovascular ischemic events. , 2006, Mayo Clinic proceedings.

[429]  J. Harrer,et al.  Stroke Recurrence and its Prevention in Patients with Patent Foramen Ovale , 2006, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[430]  J Michael Gaziano,et al.  Healthy lifestyle and the risk of stroke in women. , 2006, Archives of internal medicine.

[431]  Fernando Costa,et al.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. , 2006, Current opinion in cardiology.

[432]  T. Steiner,et al.  Intracerebral Hemorrhage Associated With Oral Anticoagulant Therapy: Current Practices and Unresolved Questions , 2006, Stroke.

[433]  C. Davie,et al.  Stroke and pregnancy , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[434]  T. Fabian,et al.  Antithrombotic therapy and endovascular stents are effective treatment for blunt carotid injuries: results from longterm followup. , 2007, Journal of the American College of Surgeons.

[435]  T. Turan,et al.  Relationship Between Blood Pressure and Stroke Recurrence in Patients With Intracranial Arterial Stenosis , 2007, Circulation.

[436]  S. Mayer,et al.  Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. , 2007, Mayo Clinic proceedings.

[437]  J. Manson,et al.  Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. , 2007, JAMA.

[438]  Adnan I. Qureshi,et al.  Guidelines for the Early Management of Adults With Ischemic Stroke , 2007 .

[439]  J. Saver,et al.  High-Density Lipoprotein Cholesterol: An Emerging Target for Stroke Treatment , 2007, Stroke.

[440]  P. Heuschmann,et al.  Stroke mortality and morbidity attributable to passive smoking in Germany , 2007, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[441]  M. Hennerici,et al.  Effects of Intense Low-Density Lipoprotein Cholesterol Reduction in Patients With Stroke or Transient Ischemic Attack: The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial , 2007, Stroke.

[442]  Jennifer G. Robinson,et al.  Is it Time for a Cardiovascular Primary Prevention Trial in the Elderly? , 2007, Stroke.

[443]  K. Furie,et al.  Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2008, Circulation.

[444]  A. Algra,et al.  Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial , 2007, The Lancet Neurology.

[445]  R. Finkel,et al.  Agalsidase-Beta Therapy for Advanced Fabry Disease , 2007, Annals of Internal Medicine.

[446]  M. Hanefeld,et al.  Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study. , 2007, Journal of the American College of Cardiology.

[447]  M. Schwerzmann,et al.  Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolism , 2007, Heart.

[448]  Shotai Kobayashi,et al.  Early Recurrence of Ischemic Stroke in Japanese Patients: The Japan Standard Stroke Registry Study , 2007, Cerebrovascular Diseases.

[449]  S. Kasner,et al.  Risk factor status and vascular events in patients with symptomatic intracranial stenosis , 2007, Neurology.

[450]  D. McCabe,et al.  Long-Term Outcome After Angioplasty and Stenting for Symptomatic Vertebral Artery Stenosis Compared With Medical Treatment in the Carotid And Vertebral Artery Transluminal Angioplasty Study (CAVATAS): A Randomized Trial , 2007, Stroke.

[451]  Xiping Xu,et al.  Efficacy of folic acid supplementation in stroke prevention: a meta-analysis , 2007, The Lancet.

[452]  R. Macko,et al.  Treadmill Aerobic Training Improves Glucose Tolerance and Indices of Insulin Sensitivity in Disabled Stroke Survivors: A Preliminary Report , 2007, Stroke.

[453]  D. Betteridge,et al.  Effects of Pioglitazone in Patients With Type 2 Diabetes With or Without Previous Stroke: Results From PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04) , 2007, Stroke.

[454]  J. Charrow,et al.  Sustained, long-term renal stabilization after 54 months of agalsidase beta therapy in patients with Fabry disease. , 2007, Journal of the American Society of Nephrology : JASN.

[455]  T. Wilkinson,et al.  The risk of recurrent stroke after intracerebral haemorrhage , 2007, Journal of Neurology, Neurosurgery & Psychiatry.

[456]  H. Woo,et al.  A 7‐YEAR EXPERIENCE WITH BALLOON‐MOUNTED CORONARY STENTS FOR THE TREATMENT OF SYMPTOMATIC VERTEBROBASILAR INTRACRANIAL ATHEROMATOUS DISEASE , 2007, Neurosurgery.

[457]  R. Ware,et al.  Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia. , 2007, Blood.

[458]  D. Germain Fabry disease: the need to stratify patient populations to better understand the outcome of enzyme replacement therapy. , 2007, Clinical therapeutics.

[459]  J. Douketis,et al.  Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials. , 2007, Archives of internal medicine.

[460]  J. Farmer High-dose atorvastatin after stroke or transient ischemic attack. , 2007, Current atherosclerosis reports.

[461]  Gustavo Saposnik,et al.  Weekends: A Dangerous Time for Having a Stroke? , 2007, Stroke.

[462]  J. Tobis,et al.  Five-year experience with percutaneous closure of patent foramen ovale. , 2007, The American journal of cardiology.

[463]  A. Selwyn Weight reduction and cardiovascular and metabolic disease prevention: clinical trial update. , 2007, The American journal of cardiology.

[464]  P. Ridker,et al.  Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. , 2007, JAMA.

[465]  R. Sacco,et al.  Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. , 2007, Journal of the American College of Cardiology.

[466]  H. Woo,et al.  US Multicenter Experience With the Wingspan Stent System for the Treatment of Intracranial Atheromatous Disease: Periprocedural Results , 2007, Stroke.

[467]  R. Devereux,et al.  Relation between mitral annular calcium and complex aortic atheroma in patients with cerebral ischemia referred for transesophageal echocardiography. , 2007, The American journal of cardiology.

[468]  A. Demchuk,et al.  Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial , 2007, The Lancet Neurology.

[469]  H. Diener,et al.  Secondary Stroke Prevention With Ximelagatran Versus Warfarin in Patients With Atrial Fibrillation: Pooled Analysis of SPORTIF III and V Clinical Trials , 2007, Stroke.

[470]  G. Webb,et al.  Recurrent Stroke/TIA in Cryptogenic Stroke Patients with Patent Foramen Ovale , 2007, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[471]  M. Hartmann,et al.  A Novel, Self-Expanding, Nitinol Stent in Medically Refractory Intracranial Atherosclerotic Stenoses: The Wingspan Study , 2007, Stroke.

[472]  D. Mikhailidis,et al.  Association of Drinking Pattern and Alcohol Beverage Type With the Prevalence of Metabolic Syndrome, Diabetes, Coronary Heart Disease, Stroke, and Peripheral Arterial Disease in a Mediterranean Cohort , 2007, Angiology.

[473]  B. Ovbiagele Statin therapy after stroke or transient ischemic attack—a new weapon in our secondary stroke prevention arsenal? , 2007, Nature Clinical Practice Neurology.

[474]  M. Olschewski,et al.  Patent foramen ovale and cryptogenic stroke in older patients. , 2007, The New England journal of medicine.

[475]  S. Kaul,et al.  Role of Clopidogrel in Managing Atherothrombotic Cardiovascular Disease , 2007, Annals of Internal Medicine.

[476]  M. Kaste,et al.  Prognosis and Safety of Anticoagulation in Intracranial Artery Dissections in Adults , 2007, Stroke.

[477]  C. Leissinger,et al.  Role of prothrombin complex concentrates in reversing warfarin anticoagulation: A review of the literature , 2008, American journal of hematology.

[478]  D. Giugliano,et al.  Are there specific treatments for the metabolic syndrome? , 2008, The American journal of clinical nutrition.

[479]  N. Feldstein,et al.  Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis. , 2008, Journal of neurosurgery. Pediatrics.

[480]  Edward R. Smith,et al.  Management of Stroke in Infants and Children: A Scientific Statement From a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young , 2008, Stroke.

[481]  J. Douketis,et al.  The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.

[482]  M. Wasay,et al.  Cerebral Venous Thrombosis: A Descriptive Multicenter Study of Patients in Pakistan and Middle East , 2008, Stroke.

[483]  Vivian Gu,et al.  Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. , 2008, The New England journal of medicine.

[484]  S. Kutty,et al.  Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder. , 2008, The American journal of cardiology.

[485]  B. Ovbiagele,et al.  Drug Insight: translating evidence on statin therapy into clinical benefits , 2008, Nature Clinical Practice Neurology.

[486]  E. Pezalla,et al.  Initial assessment of clinical impact of a drug interaction between clopidogrel and proton pump inhibitors. , 2008, Journal of the American College of Cardiology.

[487]  H. Markus,et al.  Treatment of cervical artery dissection: a systematic review and meta-analysis , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[488]  B. Nordestgaard,et al.  NON-FASTING TRIGLYCERIDES AND RISK OF ISCHEMIC STROKE IN THE GENERAL POPULATION , 2008 .

[489]  A. Lindgren,et al.  Risk Factors and Treatment at Recurrent Stroke Onset: Results from the Recurrent Stroke Quality and Epidemiology (RESQUE) Study , 2008, Cerebrovascular Diseases.

[490]  H. Milionis,et al.  Metabolic Syndrome and Its Components as Predictors of Ischemic Stroke in Type 2 Diabetic Patients , 2008, Stroke.

[491]  S. Yusuf,et al.  Telmisartan to prevent recurrent stroke and cardiovascular events. , 2008, The New England journal of medicine.

[492]  J. Manson,et al.  Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society , 2008, Menopause.

[493]  D. Liebeskind,et al.  Association of serum lipid indices with large artery atherosclerotic stroke , 2008, Neurology.

[494]  M. Hennerici,et al.  Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study , 2008, Neurology.

[495]  G. Guyatt,et al.  The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.

[496]  M. Balbi,et al.  Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events. , 2008, American heart journal.

[497]  N. Lefèvre,et al.  Use of hydroxyurea in prevention of stroke in children with sickle cell disease. , 2008, Blood.

[498]  S. Warach,et al.  Racial differences in microbleed prevalence in primary intracerebral hemorrhage , 2008, Neurology.

[499]  C. Loftus,et al.  The timing of carotid endarterectomy post stroke. , 2008, Neurosurgery clinics of North America.

[500]  Z. Hong,et al.  Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study , 2008, The Lancet Neurology.

[501]  Margaret Anderson,et al.  Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. , 2008, JAMA.

[502]  H. Lutsep,et al.  The NIH registry on use of the Wingspan stent for symptomatic70–99% intracranial arterial stenosis , 2008, Neurology.

[503]  J. Martí-Fàbregas,et al.  Recurrent Stroke and Massive Right-to-Left Shunt: Results From the Prospective Spanish Multicenter (CODICIA) Study , 2008, Stroke.

[504]  U. Wisløff,et al.  Aerobic Interval Training Versus Continuous Moderate Exercise as a Treatment for the Metabolic Syndrome: A Pilot Study , 2008, Circulation.

[505]  Veikko Salomaa,et al.  Increased Stroke Risk Is Related to a Binge Drinking Habit , 2008, Stroke.

[506]  G. Logroscino,et al.  The metabolic syndrome: more than the sum of its components? , 2008, Stroke.

[507]  E. Ringelstein,et al.  Morphometric analysis of collagen fibrils in skin of patients with spontaneous cervical artery dissection , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[508]  J. Manson,et al.  Postmenopausal hormone therapy and stroke: role of time since menopause and age at initiation of hormone therapy. , 2008, Archives of internal medicine.

[509]  A. Terashi,et al.  Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS): A Randomized, Double-Blind, Aspirin-Controlled Trial , 2008, Stroke.

[510]  M. Laakso,et al.  The Metabolic Syndrome Predicts Incident Stroke: A 14-Year Follow-Up Study in Elderly People in Finland , 2008, Stroke.

[511]  Z. Amoura,et al.  Changes in Enoxaparin Pharmacokinetics During Pregnancy and Implications for Antithrombotic Therapeutic Strategy , 2008, Clinical pharmacology and therapeutics.

[512]  G. Raskob,et al.  Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.

[513]  J. Broderick,et al.  Warfarin use leads to larger intracerebral hematomas , 2008, Neurology.

[514]  J. Hirsh,et al.  Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.

[515]  R. Sacco,et al.  Metabolic Syndrome and Ischemic Stroke Risk: Northern Manhattan Study , 2008, Stroke.

[516]  P. Macfarlane,et al.  Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies , 2008, The Lancet.

[517]  D. Singer,et al.  Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.

[518]  B. Nordestgaard,et al.  Nonfasting triglycerides and risk of ischemic stroke in the general population. , 2008, JAMA.

[519]  Grant D. Huang,et al.  Glucose control and vascular complications in veterans with type 2 diabetes. , 2009, The New England journal of medicine.

[520]  A. Roguin,et al.  Incidence of early left ventricular thrombus after acute anterior wall myocardial infarction in the primary coronary intervention era. , 2009, American heart journal.

[521]  S. Yusuf,et al.  Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[522]  V. Rousson,et al.  Aspirin vs anticoagulation in carotid artery dissection , 2009, Neurology.

[523]  Salim Yusuf,et al.  Effect of clopidogrel added to aspirin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[524]  Maurice Buchbinder,et al.  Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial , 2009, The Lancet.

[525]  Li Liang,et al.  Get With the Guidelines–Stroke Is Associated With Sustained Improvement in Care for Patients Hospitalized With Acute Stroke or Transient Ischemic Attack , 2009, Circulation.

[526]  P. Heuschmann,et al.  Long-Term Effects of Specialized Stroke Care With Telemedicine Support in Community Hospitals on Behalf of the Telemedical Project for Integrative Stroke Care (TEMPiS) , 2009, Stroke.

[527]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[528]  R. Schnabel,et al.  Long term follow up after percutaneous closure of PFO in 357 patients with paradoxical embolism: Difference in occlusion systems and influence of atrial septum aneurysm. , 2009, International journal of cardiology.

[529]  E. Tuzcu,et al.  Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials. A science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation. , 2009, Journal of the American College of Cardiology.

[530]  L. Mascitelli,et al.  HEMORRHAGIC STROKE IN THE STROKE PREVENTION BY AGGRESSIVE REDUCTION IN CHOLESTEROL LEVELS STUDY , 2009, Neurology.

[531]  E. Antman,et al.  Cytochrome p-450 polymorphisms and response to clopidogrel. , 2009, The New England journal of medicine.

[532]  Executive Summary: Standards of Medical Care in Diabetes—2009 , 2009, Diabetes Care.

[533]  J. Tuomilehto,et al.  Comparison of Definitions of Metabolic Syndrome in Relation to the Risk of Developing Stroke and Coronary Heart Disease in Finnish and Swedish Cohorts , 2009, Stroke.

[534]  Eric E. Smith,et al.  Off-Hour Admission and In-Hospital Stroke Case Fatality in the Get With The Guidelines-Stroke Program , 2009, Stroke.

[535]  V. Basevi Standards of Medical Care in Diabetes—2010 , 2010, Diabetes Care.

[536]  I-Min Lee,et al.  Physical Activity and Risk of Stroke in Women , 2010, Stroke.

[537]  Michael D Hill,et al.  Stenting versus endarterectomy for treatment of carotid-artery stenosis. , 2010, The New England journal of medicine.